Get started
Author

Frank W J Heijboer

Observed names: F. Heijboer, F. W. J. Heijboer, F.W.J. Heijboer, Frank Heijboer, Frank W. J. Heijboer, Frank W.J. Heijboer
ORCID: 0009-0009-4108-3969
Observed ORCID: 0009-0009-4108-3969
OpenAlex ID: A5081136839
Time-saving opportunities in knee osteoarthritis: T2 mapping and structural imaging of the knee using a single 5-min MRI scan
2019 · Susanne M. Eijgenraam, Akshay S. Chaudhari, et al. · European Radiology · 41
PDF
Hepatotoxicity in patients with non-small cell lung cancer treated with sotorasib after prior immunotherapy: a comprehensive clinical and pharmacokinetic analysis
2024 · Sophie M. Ernst, Maaike M. Hofman, et al. · EBioMedicine · 31
PDF
Pneumomediastinum in a patient with COVID-19 due to diffuse alveolar damage
2021 · Frank Heijboer, Laurien Oswald, et al. · BMJ Case Reports · 7
PDF
Radiological follow-up in patients with resected pulmonary carcinoids: Should we reduce radiation exposure?
2024 · F.W.J. Heijboer, T.A. Mulders, et al. · Lung Cancer · 6
Case-control study of patient characteristics, knowledge of the COVID-19 disease, risk behaviour and mental state in patients visiting an emergency room with COVID-19 symptoms in the Netherlands
2021 · J. P. M. van der Valk, F. W. J. Heijboer, et al. · PLoS ONE · 6
PDF
Treatment outcomes in patients with stage IV large cell neuroendocrine carcinoma: a nationwide registry study
2025 · Frank W.J. Heijboer, Jules L. Derks, et al. · Lung Cancer · 5
PDF
Actionable Genomic Alterations in Large Cell Neuroendocrine Carcinoma: A European Case Series of Patients Treated With a Small Molecule Inhibitor
2025 · Frank W.J. Heijboer, Marta Brambilla, et al. · JCO Precision Oncology · 4
Clinical insight on the pathway of SLFN11 as emergent biomarker in SCLC
2025 · Daniela Scattolin, Frank W.J. Heijboer, et al. · Critical Reviews in Oncology/Hematology · 4
Comprehensive Analysis of Neurogenic Differentiation Factor 1 (NEUROD1), Achaete-Scute Homolog 1 (ASCL1), POU Class 2 Homeobox 3 (POU2F3), and Yes-Associated Protein 1 (YAP1) Expression Signatures Reveals Unique Large-Cell Neuroendocrine Carcinoma (LCNEC) Subgroups With Potential Therapeutic Implications
2025 · Frank W.J. Heijboer, Jules L. Derks, et al. · Laboratory Investigation · 3
Deep Learning–Based Retinoblastoma Protein Subtyping of Pulmonary Large-Cell Neuroendocrine Carcinoma on Small Hematoxylin and Eosin–Stained Specimens
2025 · Teodora E. Trandafir, Frank W.J. Heijboer, et al. · Laboratory Investigation · 2
Pulmonary Neuroendocrine Tumor Artificial Intelligence–Assisted Prediction of Postoperative Recurrence From Tumor Biopsy Specimens
2026 · Farhan Akram, Teodora E. Trandafir, et al. · Modern Pathology · 1
Clinical utility of molecular profiling in rare lung neuroendocrine neoplasms
2026 · Daphne Leunissen, Laura Moonen, et al. · Frontiers in Oncology
PDF
Quality in Central Pathology Assessment in Pulmonary Carcinoid and Large Cell Neuroendocrine Carcinoma: A Systematic Review
2026 · Frank W.J. Heijboer, Daniela Scattolin, et al. · Modern Pathology
Analysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasms
2026 · Daniela Scattolin, Frank W.J. Heijboer, et al. · Lung Cancer
453P SLFN11 expression across lung neuroendocrine neoplasms (NENs): Small cell lung cancer (SCLC), typical and atypical carcinoids (TC/AC) and large cell neuroendocrine carcinoma (LCNEC)
2026 · D. Scattolin, F. Heijboer, et al. · ESMO Open
PDF
429P: Real-world versus pathology panel-reviewed treatment outcomes in patients with stage IV LCNEC: A nationwide registry study
2025 · F.W.J. Heijboer, J. Derks, et al. · Journal of Thoracic Oncology
PDF
2202P Large cell neuroendocrine carcinoma (LCNEC) subtyping based on NEUROD1, ASCL1, POU2F3 and YAP1 expression
2023 · F. Heijboer, J. Derks, et al. · Annals of Oncology
PDF
Patient Characteristics, Knowledge of the COVID-19 Disease, Risk Behaviour and Mental State in Patients Visiting an Emergency Room with COVID-19 Symptoms in the Netherlands
2020 · J.P.M van der Valk, F.W.J. Heijboer, et al. · SSRN Electronic Journal
Works count: 18
Citation count: 110
H-index: 5
I10-index: 2
Year
Topic
Type